Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Seattle Biotech -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (20)	8/9/2000 6:13:24 AM
From: Mike McFarland	Respond to of 70

RSTA completed an initial public offering of 7,200,000 shares of its common stock at a price of $14 per share Message 14185237 Tredegar announces holdings bizjournals.com When Rosetta went public last Thursday, its stock debuted at $16.25, higher than its expected $14 offering price. On Monday, it closed at $19.75 Message 14185181 Message 14155096 _______________________________________________________ fwiw, I do not own rsta, marketcap for this local newbie is just too high for me--as interesting as it seems with Hood and Hartwell involved at one time. But I'll be watching it. I did lousy getting into TBIO, another interesting pick and shovel biotech, and really got hammered on sgmo initially too--guess I just don't have the knack for how to make money in the early going on these IPOs. No rush on RSTA I think.